-The Economic Times NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe. "At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia," a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET. The Australian...
More »SEARCH RESULT
Total Matching Records found : 1231
68% of milk does not meet food norms: Centre tells SC
-The Times of India NEW DELHI: Common nutritional supplement milk you take may not be all that nutritious as an overwhelming majority of samples of milk supplied across the country failed to meet the food safety and standard norms. The Centre on Tuesday dished out startling fact about the health of milk supplied both loose or in packets and informed the Supreme Court that 68.4% of the samples collected from rural and...
More »Exclusion as policy -TK Rajalakshmi
-Frontline Attempts by the Congress-led UPA government to adopt the ordinance route to pass the Food Security Bill fail as the opposition parties are more or less united in seeking a Bill that provides universal PDS coverage. THE National Food Security Bill (NFSB), 2013, touted as the biggest game changer for the Congress-led United Progressive Alliance (UPA) government in the 2014 parliamentary elections, will go through yet another round of discussions...
More »Ignore Lancet series, experts tell Centre -Rema Nagarajan
-The Times of India NEW DELHI: Several nutrition experts and members of the Indian Academy of Paediatrics, the largest association of paediatricians in India, have warned that the new set of papers on malnutrition published in the medical journal, Lancet, "should not be allowed to become an opportunity for commercial exploitation of malnutrition". "The call for engaging with the "private sector" and unregulated marketing of commercial foods for preventing malnutrition in children...
More »Indian drug makers face heat of US regulator's crackdown-Sushmi Dey
-The Business Standard Data also show that several other leading domestic pharma companies have recalled their products from the US Frequent drug recalls, warning letters and import alerts from the US in the recent past have turned into a major concern for the Indian pharmaceutical industry and investors. While Ranbaxy Laboratories recently pleaded guilty before the US authorities for its wrongdoings in the past, the crackdown on the drug companies seems to...
More »
